SELLAS Life Sciences Group, Inc. received a notice from Nasdaq stating that their common stock did not maintain a minimum closing bid price of $1.00 per share as required by Nasdaq Listing Rule 5550(a)(2). The company has a grace period of 180 days to regain compliance.